May 032018

The Johnson and Johnson iMerge trial testing Geron’s Imetelstat for Myelodysplastic Syndrom was updated today (see; obtained on 5-3-18).

The author owns shares of Geron.


The Hygiology Post ® welcomes feedback from readers as to whether the articles (individually and/or collectively) help fulfill its vision and mission.


Louis DeCola, Jr.  © 2018                                    The Hygiology Post ®